Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Selective Angiotensin II Receptor Antagonists

Known as: Sartans 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Angiotensin II receptor blockers (ARBs, collectively called sartans) are widely used compounds therapeutically effective in… Expand
Highly Cited
2015
Highly Cited
2015
See Moon (doi:10.1093/awv239) for a scientific commentary on this article.Traumatic brain injury frequently leads to long-term… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
Sartans (Angiotensin II AT(1) Receptor Blockers, ARBs) are powerful neuroprotective agents in vivo and protect against IL-1… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2009
Review
2009
Sartans are non-peptide AT(1) receptor antagonists used to treat hypertension and related pathologies. Their effects on the G… Expand
Highly Cited
2009
Highly Cited
2009
Background This study is aimed to assess the prevalence of awareness, treatment and control of high blood pressure (HBP) and… Expand
Highly Cited
2006
Highly Cited
2006
OBJECTIVE AND DESIGN Elevated blood pressure and insulin resistance are strongly associated in patients. We explored the… Expand
Highly Cited
2006
Highly Cited
2006
OBJECTIVE AND DESIGN: Elevated blood pressure and insulin resistance are strongly associated in patients. We explored the… Expand
Highly Cited
2006
Highly Cited
2006
Angiotensin receptor blockers (ARBs), also known as sartans, block the activation of angiotensin type 1 receptors and have a… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2000
Highly Cited
2000
AbstractObjective: Metabolic interactions at the level of drug-metabolising enzymes are important for drug therapy. We… Expand
  • table 1
  • figure 1
Review
1999
Review
1999
  • P. Timmermans
  • The Canadian journal of cardiology
  • 1999
  • Corpus ID: 24694991
The availability of selective, potent, orally active and long acting nonpeptide angiotensin II type 1 (AT1) receptor antagonists… Expand